Wellington Management Group LLP decreased its position in Chemed Co. (NYSE:CHE - Free Report) by 30.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,244 shares of the company's stock after selling 998 shares during the quarter. Wellington Management Group LLP's holdings in Chemed were worth $1,189,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. UMB Bank n.a. grew its stake in shares of Chemed by 300.0% in the 4th quarter. UMB Bank n.a. now owns 52 shares of the company's stock worth $28,000 after buying an additional 39 shares in the last quarter. Atala Financial Inc bought a new stake in Chemed during the fourth quarter worth approximately $29,000. CBIZ Investment Advisory Services LLC raised its position in Chemed by 64.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock valued at $30,000 after purchasing an additional 22 shares during the period. Trust Co. of Vermont bought a new stake in shares of Chemed in the 4th quarter valued at approximately $34,000. Finally, Tortoise Investment Management LLC boosted its holdings in shares of Chemed by 77.3% in the 4th quarter. Tortoise Investment Management LLC now owns 78 shares of the company's stock worth $41,000 after purchasing an additional 34 shares during the period. 95.85% of the stock is currently owned by institutional investors.
Insider Buying and Selling
In other Chemed news, CEO Kevin J. Mcnamara sold 1,000 shares of the stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $615.33, for a total transaction of $615,330.00. Following the completion of the sale, the chief executive officer now directly owns 101,679 shares of the company's stock, valued at approximately $62,566,139.07. This represents a 0.97 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 3.32% of the stock is currently owned by company insiders.
Chemed Stock Down 0.1 %
Shares of CHE stock traded down $0.86 on Friday, hitting $580.52. The stock had a trading volume of 110,655 shares, compared to its average volume of 97,899. Chemed Co. has a one year low of $512.12 and a one year high of $623.61. The business has a 50 day moving average price of $585.78 and a 200 day moving average price of $567.83. The company has a market cap of $8.48 billion, a PE ratio of 29.33, a P/E/G ratio of 2.15 and a beta of 0.49.
Chemed Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were given a dividend of $0.50 per share. The ex-dividend date was Monday, February 24th. This represents a $2.00 annualized dividend and a yield of 0.34%. Chemed's dividend payout ratio (DPR) is presently 10.05%.
Analyst Ratings Changes
CHE has been the topic of several recent analyst reports. StockNews.com raised shares of Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th. Royal Bank of Canada lifted their target price on Chemed from $633.00 to $667.00 and gave the stock an "outperform" rating in a research report on Friday, March 14th.
Read Our Latest Report on CHE
Chemed Company Profile
(
Free Report)
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Featured Stories

Before you consider Chemed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.
While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.